Clinical Trials Browser

Phase 3 × iso-sulfan blue × 1 year × Clear all

NCT03927027 2026-01-26

Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

Phase 3 Active not recruiting

Breast Neoplasms